InsidersTradesSigma
Browse the detailed record of transactions filed by Ferguson Kenneth M., Director. Director active across 1 companies, notably Cyclacel Pharmaceuticals, Inc.. Cumulatively, 2 disclosures have been recorded. The latest transaction was disclosed on 14 June 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Kenneth M. Ferguson is a Director at Cyclacel Pharmaceuticals, Inc. As a board member, he contributes to the governance of the company and to strategic decision-making. Kenneth leverages his experience to guide the company's initiatives and ensure compliance with best governance practices.